Avandia 2mg

Product manufactured by Glaxosmithkline Llc

Application Nr Approved Date Route Status External Links
NDA021071 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Avandia Is A Thiazolidinedione Antidiabetic Agent Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Important Limitations Of Use: • Due To Its Mechanism Of Action, Avandia Is Active Only In The Presence Of Endogenous Insulin. Therefore, Avandia Should Not Be Used In Patients With Type 1 Diabetes Mellitus Or For The Treatment Of Diabetic Ketoacidosis. • The Coadministration Of Avandia And Insulin Is Not Recommended [See Warnings And Precautions ( 5.1 )] . Avandia Is A Thiazolidinedione Antidiabetic Agent Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1 ) Important Limitations Of Use: • Avandia Should Not Be Used In Patients With Type 1 Diabetes Mellitus Or For The Treatment Of Diabetic Ketoacidosis. ( 1 ) • Coadministration Of Avandia And Insulin Is Not Recommended. ( 1 , 5.1 , 5.2 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rosiglitazone Maleate ROSIGLITAZONE MALEATE ZINC12358683

Comments